Walking study for young children with NF1
Part of Brain & nervous system, Cancer, Genetic & congenital clinical trials.
This study looks at how young children with NF1 walk. It aims to learn more about their movement patterns to help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be diagnosed with NF1.
- Your child must be 5 years old or younger (up to 71 months old).
- Your child must be able to walk 10 meters (about 33 feet) without help.
- Your child should not have other health conditions that affect movement.
- You (as parent or guardian) must agree to let your child take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study talks with people who have NF1 (and caregivers of children with NF1) about how visible tumors affect them. The goal is to create questionnaires that measure these concerns, which could lead to better support and treatments.
This study looks for better ways to measure how much tumor activity people with neurofibromatosis type 1 (NF1) have over time. The goal is to develop “biomarkers,” which are test results that may help doctors track disease more easily.
This study uses special MRI scans plus computer (AI) analysis to look for early, possibly cancer-related skin or tissue changes in children with neurofibromatosis type 1 (NF1). If it works, it could help doctors detect concerning changes earlier and plan care sooner.
This study looks at how children and teens with Duchenne muscular dystrophy (DMD) or spinal muscular atrophy (SMA) walk, by having them do walking tests while wearing sensors. The goal is to find better ways to track how these diseases progress and how treatments work over time, without needing blood tests or scans.
This study looks at how children with cerebral palsy walk compared to healthy children. Researchers use small sensors to measure movement, and the goal is to better understand walking problems.
This study looks at how children with FSHD move and function over time. It uses walking tests and optional MRI scans to understand muscle changes. Your child's participation could help researchers learn more about FSHD progression in kids.
Hear when a new Neurofibromatosis Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.